CytoDyn Inc.

SEC filing

Pharmaceuticals · Vancouver, WA

Form D on EDGAR

Amount raised$18.6Msold at filing

Total offering$18.6M

Investors in the raise194count reported to the SEC

FiledMay 11, 2026first sale Jan 30, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Tanya D. UrbachDirector

Stephen M. SimesDirector

Lishomwa C. Ndhlovu, M.D., Ph.D.Director

Robert E. HoffmanExecutive Officer

Jacob P. LalezariExecutive Officer

Karen J. Brunke, Ph.D.Director

Tyler E. BlokExecutive Officer

Ryan M. DunlapDirector

Executive officers, directors and promoters as listed on the Form D.